Astellas, Indian Generic Cos. Settle IP Fight Over Bladder Drug
Astellas Pharma Inc. has recently reached settlements with a pair of Indian drugmakers that are aiming to make generic versions of its patent-protected overactive bladder treatment Myrbetriq....To view the full article, register now.
Already a subscriber? Click here to view full article